-
Some Diabetes Drug Classes Show Promise in Reducing AD Risk
25 Sep 2025 11:25 GMT
TOPLINE:
Among diabetes drugs, GLP- … inhibitors (alogliptin, linagliptin, saxagliptin, and sitagliptin).
Risk … treatment effects for AD,” the investigators wrote.
“Randomized controlled trials … ties with various pharmaceutical, assessment, and investment …
-
July - September 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
29 Aug 2025 20:22 GMT
… (ocrelizumab)
Myocardial infarction
FDA determined that no action … canagliflozin)
Jardiance (empagliflozin)
Qtern (saxagliptin and dapagliflozin)
Steglatro (ertugliflozin)
… (solriamfetol hydrochloride)
Hypersensitivity
FDA determined that no action is …
-
Oral Antidiabetic Drugs Market to Reach $86.92 Billion by 2029 with 6.8% CAGR
22 Aug 2025 18:03 GMT
… medical treatments, drugs, or procedures. For example, Eli Lilly and Company, an American pharmaceutical … During clinical trials, orforglipron … Diabetes, Gestational Diabetes, Type 1 Diabetes
… Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, …
-
Diabetes Care Drugs Market Projected to Witness a Growth of US $90.5 Billion by 2029 | The Business Research Company
21 Aug 2025 07:59 GMT
… Diabetes Care Drugs Market?
The market for diabetic care medicines … , development of combination treatments and fixed-dose formulas … SA, a French pharmaceutical firm, in April 2024 … DPP)‑4 Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
5) …
-
‘People’s well-being at the center’: Toby Tiangco lauds VAT exemptions for more essential medicines
06 Jul 2025 05:14 GMT
… list of drugs exempted from VAT, including those for cancer, diabetes, and … directed the Food and Drug Administration (FDA) to identify medicines that should be … /24.5 mg).
For diabetes: Saxagliptin+Dapagliflozin 5 mg/10 …
-
Incretin-Based Drugs Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
01 Jul 2025 10:51 GMT
… -linked diabetes, development in personalized medicine and … treatment options for type 2 diabetes. In December 2024, Hikma Pharmaceuticals … States. The drug received FDA approval and … , saxagliptin, linagliptin, alogliptin, and vildagliptin. The drugs are …
-
Fresh antitrust guidelines to address pharmaceutical monopoly issues in China
27 Jun 2025 00:39 GMT
… holder of a pharmaceutical patent (usually the original drug company) provides monetary … against the relevant patents of Saxagliptin tablets, in exchange for BMS … Application of Law in the Trial of Civil Dispute Cases Arising …
-
9 more medicines now exempt from value added tax, says BIR
17 Jun 2025 05:13 GMT
… VAT-exempt medicines endorsed by the Food and Drug Administration (FDA) of the … Department of Health (DOH).
The newly exempted medicines … said that for diabetes, the new VAT-exempt medicines are Saxagliptin (as hydrochloride …
-
BIR exempts 9 more medicines from VAT
16 Jun 2025 23:42 GMT
… VAT-exempt medicines endorsed by the Food and Drug Administration (FDA) of the … (as mesylate), Lenalidomide, and Paclitaxel.
Diabetes: Saxagliptin (as hydrochloride) + Dapagliflozin (as … never be a barrier to medical treatment, no Filipino should have …
-
9 more essential medicines exempted from VAT
24 Apr 2025 18:04 GMT
… Drug Administration (FDA) has added nine drug products to the list of essential medicines … infusion).
Meanwhile, medicine for diabetes added to the list is Saxagliptin (as hydrochloride …
About
© 1995-2025